Taranu Daniela, Balz Luisa T, Holbrook Jill, Tumani Visal, Schreiber Herbert, Tumani Hayrettin, Uttner Ingo
Department of Neurology, Faculty of Medicine, Ulm University, D-89071, Ulm, Germany.
Department of Psychiatry, Faculty of Medicine, Ulm University, D-89071, Ulm, Germany.
J Neurol. 2025 May 14;272(6):398. doi: 10.1007/s00415-025-13115-y.
Multiple sclerosis (MS) subtypes-relapsing-remitting (RRMS), secondary-progressive (SPMS), and primary-progressive (PPMS) - have been associated with distinct cognitive impairment profiles, with progressive subtypes, in contrast to RRMS, showing additional deficits in more widespread domains. Research has largely focused on RRMS, leaving SPMS and PPMS underexplored due to their lower prevalence and limited therapeutic targeting. Data on the interplay between cognitive impairment, mood, and fatigue over time are also scarce. This study examined cognition, fatigue, and psychopathology over a period of one year to identify subtype-specific impairments and progression trajectories.
Sixty-six MS patients (22 each with RRMS, SPMS, and PPMS) and 22 healthy controls (HC) were assessed using neuropsychological tests for attention, memory, processing speed, working memory, fluency and visuospatial functions. Patient-reported outcomes for depression, anxiety, and fatigue were also collected. Analyses included correlations, within-group comparisons (paired t-tests), and between-group comparisons (ANOVAs/ANCOVAs).
Progressive MS subtypes exhibited more severe cognitive impairments, fatigue, and mood disturbances than RRMS. Over one year, treated RRMS patients improved in various cognitive domains, while PPMS patients showed gains only in visuospatial abilities. On the other hand, SPMS patients exhibited no significant changes, suggesting more pronounced cognitive deficits.
Cognitive impairments differed significantly across MS subtypes. While RRMS patients improved over one year and PPMS patients showed selective gains in one domain, SPMS showed no significant changes, indicating reduced cognitive reserve. These between-group differences suggest different cognitive trajectories. The findings underscore the need for tailored, holistic interventions for different MS subtypes.
多发性硬化症(MS)的亚型——复发缓解型(RRMS)、继发进展型(SPMS)和原发进展型(PPMS)——与不同的认知障碍特征相关,与RRMS相比,进展型亚型在更广泛的领域表现出额外的缺陷。研究主要集中在RRMS上,由于SPMS和PPMS的患病率较低且治疗靶点有限,对它们的研究较少。关于认知障碍、情绪和疲劳随时间相互作用的数据也很稀少。本研究在一年的时间里对认知、疲劳和精神病理学进行了检查,以确定亚型特异性损伤和进展轨迹。
使用神经心理学测试对66名MS患者(RRMS、SPMS和PPMS各22名)和22名健康对照者(HC)进行注意力、记忆力、处理速度、工作记忆、流畅性和视觉空间功能的评估。还收集了患者报告的抑郁、焦虑和疲劳结果。分析包括相关性分析、组内比较(配对t检验)和组间比较(方差分析/协方差分析)。
与RRMS相比,进展型MS亚型表现出更严重的认知障碍、疲劳和情绪障碍。在一年的时间里,接受治疗的RRMS患者在各个认知领域都有改善,而PPMS患者仅在视觉空间能力方面有所提高。另一方面,SPMS患者没有显著变化,表明存在更明显的认知缺陷。
MS各亚型的认知障碍存在显著差异。虽然RRMS患者在一年中有所改善,PPMS患者在一个领域有选择性的提高,但SPMS没有显著变化,表明认知储备减少。这些组间差异表明了不同的认知轨迹。研究结果强调了针对不同MS亚型进行量身定制的整体干预的必要性。